MMP3 and pterygium: The present in vivo and in vitro bevacizumab results (Figs 5, 6, 7 and 8) indicate that there was a strong correlation between the inhibition of MMP-3 and MMP-13 expression by bevacizumab and the inhibition of pterygium fibroblast migration.